1. {acid 4 - (2 - 3,5-bis (trifluorometil) - (2R, 4S) - 1 - (etoxicarbonil) - 2-ethyl 6 - (trifluoromethyl) - 1,2,3,4-tetrahydroquin-4-il) amine} pirimidin-5-il) oxi butnoico} as a transfer protein inhibitor of acetylcholesterol (CETP) and compounds containing the substance

摘要

It refers to the compound objectitrapib (acido 4 - [(2 - [3,5-bis (triflurometil) bencil] - [(2R, 4S) - 1-etoxicarbonil-2-ethyl-6-trifluorometil-1,2,3,4-tetrahydroquin-4-il] amine} pirimidin-5-il] oxi] butanico or a pharmaceutically acceptable salt, which is a transfer protein inhibitor of ethyl ethyl ethanol (CETP). It also refers to pharmacology composers, including objectitrapib or pharmaceutically acceptable salts. Obicetrapib is an effective treatment for people who have or are likely to have cardiovascular disease, especially high-fat and / or degreasing disease.